InvestorsHub Logo
Followers 57
Posts 4853
Boards Moderated 0
Alias Born 02/11/2020

Re: None

Thursday, 12/23/2021 3:10:27 PM

Thursday, December 23, 2021 3:10:27 PM

Post# of 110
$9.00 PT put on it today
Qualigen Therapeutics, Inc. ("QLGN") is a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation.

Zacks Small-Cap Research Report Has Issued a $9 Price Target.
Shorts better close it out, next week could be a lot more of pain if they don't.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QLGN News